From the Editor

It is not your mother/father’s ASCO anymore…


 

Well, what just happened in Chicago? Nearly 30,000 of our closest friends and colleagues descended on the windy city to meet in the McCormick Center to catch up on the latest data and updates in oncology at the American Society of Clinical Oncology's annual conference. What a marathon meeting it was. Who remembers when the meeting was held in one hotel (can you believe it), then two hotels, and then eventually shifted to convention centers to accommodate the burgeoning numbers of attendees? The program format is also quite different now than it was at the outset.
Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Significant response to lacosamide in a patient with severe chemotherapy-induced peripheral neuropathy
MDedge Hematology and Oncology
VIDEO: Level of e-cigarette power contributes to potentially hazardous effects
MDedge Hematology and Oncology
Cancer survivors’ informational needs vary by time, cancer type
MDedge Hematology and Oncology
Less intensive childhood cancer therapy reduces late toxicities, deaths
MDedge Hematology and Oncology
ASCO: Precision medicine initiatives take wing
MDedge Hematology and Oncology
Three bisphosphonates found on par in early breast cancer
MDedge Hematology and Oncology
ICOO: Opioid self-dosing falls short of pain control
MDedge Hematology and Oncology
ASCO: Adjuvant denosumab halves fracture risk for breast cancer patients on AIs
MDedge Hematology and Oncology
ICOO: Quality metrics needed for medical marijuana
MDedge Hematology and Oncology
ICOO: Approach to opioids for cancer pain evolves
MDedge Hematology and Oncology